Sometimes, diabetes science confuses me.Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.Sodium-glucose transporter (SGLT-2) inhibitors i…
SOURCE: Healthline RSS Feed – Read entire story here.